NU SKIN ENTERPRISES, INC.

Nu Skin Enterprises, Inc. has a market price of $6.75 per share, with a market capitalization of $333.598 million. The company's price-to-earnings ratio is 181.7, indicating a high valuation relative to its earnings, while its price-to-book ratio is 0.5, suggesting that the market values the company at a discount to its book value. The company's liquidity position is characterized by a current ratio of 2.03, indicating that it has sufficient current assets to cover its current liabilities. However, the company's net cash position is negative after subtracting total debt, which is a key liquidity flag. In terms of profitability, Nu Skin's return on equity is 0.0023 and return on assets is 0.0013, both of which are relatively low, indicating that the company is not generating significant returns for its shareholders or assets. The company's operating income for the quarter was $4.026 million, a significant improvement from a loss of $9.903 million in the same period last year. However, the company's gross profit margin has decreased from 67.7% in the previous year to 66.9% in the current quarter, indicating a slight decline in profitability. Nu Skin operates in several geographic regions, with a notable presence in Mainland China, South Korea, Japan, and Southeast Asia. The company's revenue concentration in these regions is a strategic focus, as it leverages the direct selling model to educate consumers on the benefits of its wellness products. The company's business model in Mainland China is structured based on guidance from government officials and an understanding of the regulatory environment. The company's growth trajectory is mixed, with a revenue decline from $364.490 million in the same period last year to $320.608 million in the current quarter. However, the company has managed to reduce its operating expenses, with total operating expenses decreasing from $256.864 million to $210.437 million. The company's capital expenditure for the quarter was $13.714 million, indicating a continued investment in its operations. Risk factors for Nu Skin include liquidity and dilution risks, with the company facing potential dilution from its financing activities. The company has a debt-to-equity ratio of 0.28, indicating a relatively low level of debt compared to its equity. However, the company's free cash flow is negative at -$17.633 million, which could impact its ability to fund operations and growth initiatives. Recent events include the company's Q1 2026 financial results, which show a net income of $1.836 million, a significant decrease from $107.515 million in the same period last year. The company has also engaged in financing activities, including the payment of dividends and repurchases of shares, which could affect its liquidity position.